Cost of Cancer Drugs: Something Has To Give

Manag Care. 2018 May;27(5):18-22.

Abstract

The drugs often are more effective and have fewer side effects. The science-often just amazing. Medically, cancer treatment has never been in a better place. But are high prices making it unaffordable? Payers, providers, policymakers, and drugmakers themselves are wrestling with the issue. Meanwhile, many patients are being priced out of treatments that could save their lives.

Keywords: Drug Costs; Health Care Costs; Pharmaceutical Economics; Pharmacoeconomics.

MeSH terms

  • Antineoplastic Agents / economics*
  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Drug Approval
  • Drug Costs / trends*
  • Drug Industry / economics*
  • Humans
  • Insurance Coverage / economics
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents